Borderline Forced Expiratory Volume in 1 Second to Forced Vital Capacity and Low Forced Expiratory Volume in 1 Second Predict Disease Progression in High-Risk Populations With COPD
Xingyao Tang, MD1,2 Wei Li, MD2 Jieping Lei, PhD2,3 Hongtao Niu, MD2 Minghui Shi, MD1,2 Jisong Yan, MD2,4 Yaodie Peng, MD2,5 Yanan Cui, MD2 Tingting Huang, MD2 Yong Li, MD2 Jun Pan, Mr6 Chunyu Zhang, PhD6 Cunbo Jia, PHD6 Xu Chu, MD2 Ting Yang, MD, PhD1,2 Ke Huang, MD1,2
Citation: Tang X, Li W, Lei J, et al. Borderline forced expiratory volume in 1 second to forced vital capacity and low forced expiratory volume in 1 second predict disease progression in high-risk populations with COPD. Chronic Obstr Pulm Dis. 2026; Published online May 11, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0700
Who Enrolls After Referral to Virtual Pulmonary Rehabilitation? A Descriptive Comparison
Emily A. Schultz, BS1 Madeleine Frank, MHSA2 Sara L. Eppler, MPH1 Melissa Dymock, MBA2 Robin N. Kamal, MD, MBA, MS1 Julia Maheshwari, MD3 Lauren E. Eggert, MD3
Citation: Schultz EA, Frank M, Eppler SL, et al. Who enrolls after referral to virtual pulmonary rehabilitation? a descriptive comparison. Chronic Obstr Pulm Dis. 2026; Published online May 11, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0729
Association of Short-Term Pollen Exposure With Lung Function in COPD Patients
James P. Healy1 Wenli Ni1,2,3 Brent Coull4 Petros Koutrakis3 Andrew Synn2 Nicholas Nassikas1,2 Mary B. Rice1,2,3
Citation: Healy JP, Ni Wenli, Coull B, et al. Association of short-term pollen exposure with lung function in COPD patients. Chronic Obstr Pulm Dis. 2026; Published online May 9, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0735
Symptomatic Changes Associated With a Pharmacist-Led COPD Program
Edward C. Portillo, PharmD1,2 Steven Do, PharmD1,2,3 Scott Hetzel, MS4 Jennifer Nguyen1 Katelynn Cleveland, MS1 Cara Ray, PhD5 Jenna Vande Hey1 Pramit Maskey, MS6 Rena Steiger-Chadwick, MPH5 Lucas M. Donovan, MD, MS7 Dylan Erdelt1 Sarah Will, PharmD, BCPS8 Michael Shawn McFarland, PharmD, FCCP, BCACP8 Heather Ourth, PharmD, BCPS, BCGP, FASHP8 Michelle Chui, PharmD, PhD9
Citation: Portillo EC, Do S, Hetzel S, et al. Symptomatic changes associated with a pharmacist-led COPD program. Chronic Obstr Pulm Dis. 2026; Published online April 16, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0716
Small Pulmonary Artery and Vein Volumes Independently Predict Oxygen Desaturation in Smokers
Anastasia K. A. L. Kwee1 Wouter A. C. van Amsterdam2 Firdaus A. A. Mohamed Hoesein1 Leticia Gallardo-Estrella3 Jean-Paul Charbonnier3 Stephen M. Humphries4 Harm A. W. M. Tiddens3 James D. Crapo5 Richard Casaburi6,7 Pim A. de Jong1 David A. Lynch4 Esther Pompe1
Citation: Kwee AKWL, van Amsterdam WAC, Mohamed Hoesein FAA, et al. Small pulmonary artery and vein volumes independently predict oxygen desaturation in smokers. Chronic Obstr Pulm Dis. 2026; Published online April 10, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0694
Reconsidering Vitamin D Supplementation in Pulmonary Disease: The Case for Targeted Respiratory Delivery
Kevin D. Schichlein1 Ilona Jaspers2 M. Bradley Drummond3
Citation: Schichlein KD, Jaspers I, Drummond MB. Reconsidering vitamin D supplementation in pulmonary disease: the case for targeted respiratory delivery. Chronic Obstr Pulm Dis. 2026; Published online March 31, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0713
Clinical Significance of Reduced Forced Expiratory Volume in 3 Seconds to Forced Expiratory Volume in 6 Seconds in Adults
Siman Liao, MD1* Juncheng Liang, MD1* Jie Ou, MD2 Ranxi Peng, MD3 Shiyu Zhang, MD4 Leheng Tang, MD4 Qiaorui Zhou, MD4 Yingtong Chen, MD4 Xiaozi Guo, MD1 Jingxian Chen, MD1 Qi Wan, MD5 Zihui Wang, MD, PhD5 Zhishan Deng, MD, PhD5 Yumin Zhou, MD, PhD5,6 Fan Wu, MD, PhD5
Citation: Liao S, Liang J, Ou J, et al. Clinical significance of reduced forced expiratory volume in 3 seconds to forced expiratory volume in 6 seconds in adults. Chronic Obstr Pulm Dis. 2026; Published online March 31, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0649
Understanding COPD Patients’ Perspectives on Utilizing Strategies to Limit Their Exposure to Wildfire Smoke
Jimmy Yao, MD, MPH1 Caitlin M. Lydon, MPH1 Nina Pak, PhD1 Kathleen A. Daly, BS1 Mary Meyer, MD, MPH2 Nadia Hansel, MD, MPH3 Mark T. Dransfield, MD4 Stacey Alexeeff, PhD1 Andrea Altshuler, PhD1 Laura C. Myers, MD, MPH1
Citation: Yao J, Lydon CM, Pak N, et al. Understanding COPD patients’ perspectives on utilizing strategies to limit their exposure to wildfire smoke. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0682
Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study
Sonal G. Mallya, MD, MHS1 Kaila Holloway, MD, MPH2 Cyd K. Eaton, PhD3 Michelle Sharp, MD, MHS1 Nirupama Putcha, MD, MHS1 Kristin A. Riekert, PhD1 Theodore J. Iwashyna, MD, PhD1 Michelle N. Eakin, PhD1
Citation: Mallya SG, Holloway K, Eaton CK, et al. Exploring the impact of financial toxicity in COPD: a qualitative study. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0712
Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada
Mohit Bhutani1 Alan Kaplan2 Sheena Kayaniyil3 Kyla Jamieson3 Ross Ormsby3 John Bell4 Prachi Bhatt5 Jennifer Carioto5 Bruce Pyenson5
Citation: Bhutani M, Kaplan A, Kayaniyil S, et al. Implementation of 2023 Canadian Thoracic Society guidelines for single-inhaler triple therapy could reduce exacerbation and mortality rates in COPD: PROMETHEUS Canada. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0687
Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health System
Drew D. Robinson, MD1,2,3 Chia-Ying Chiu, DrPH1,2 Jane I. Hampton, MD4 George M. Solomon, MD1,5 J. Michael Wells, MD, MSPH1,2,3,6
Citation: Robinson DD, Chiu CY, Hampton JI, Solomon GM, Wells JM. Clinical characteristics and health care resource utilization among individuals undergoing alpha-1 antitrypsin testing in a quaternary health system. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0723